Publication | Open Access
Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study
36
Citations
16
References
2022
Year
Patients with severe asthma treated with benralizumab experienced clinical and economic benefits in the real world, as demonstrated by the reduction in exacerbations and HCRU.
| Year | Citations | |
|---|---|---|
Page 1
Page 1